Penn medicine | virtua strategic alliance brings first proton therapy to south Jersey
PHILADELPHIA | MARLTON - Cancer care in South Jersey is about to enter a new era. Penn Medicine, in partnership ...
Search Result for 'advanced'
No Result
WPI team taking optical device from the lab to the clinic to detect cancer much earlier
Credit: Worcester Polytechnic Institute (WPI) Worcester, Mass. - In a paper published in Nature Scientific Reports, a team of researchers ...
One in 5 young colon cancer patients have genetic link
ANN ARBOR, Michigan -- As doctors grapple with increasing rates of colorectal cancers in young people, new research from the ...
1 in 5 young colon cancer patients have genetic link
ANN ARBOR, Michigan -- As doctors grapple with increasing rates of colorectal cancers in young people, new research from the ...
Plasmonic biosensors enable development of new easy-to-use health tests
Credit: Aalto University Researchers at Aalto University, Finland, have developed a biosensor that enables creating a range of new easy-to-use ...
A gold-standard cancer treatment is in decline, and money may be why
Credit: UVA Health System The evidence is clear: Cervical cancer is best treated with brachytherapy, a form of radiation therapy. ...
Medical marijuana for children with cancer? What providers think
A study published in Pediatrics examined interdisciplinary provider perspectives on legal medical marijuana use in children with cancer. It found ...
Transfusion dependence a barrier to quality end-of-life care for some with leukemia
(Atlanta, Dec. 11, 2017) -- For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in ...
CAR T-cell therapies drive outcomes in lymphoma, myeloma
Credit: American Society of Hematology (Atlanta, Dec. 10, 2017) -- For people with certain types of aggressive, refractory blood cancers, ...
TGen and Baylor poised to create early detection test for pancreatic cancer
PHOENIX and DALLAS -- Dec. 11, 2017 -- A group of the nation's premier cancer researchers led by the Baylor ...
Yeast can be engineered to create protein pharmaceuticals
Credit: Mingtao Huang/Chalmers It took several years, but a research team headed by Professor Jens Nielsen at Chalmers University of ...
Low-dose treatment with Il2 across studies shows benefits in chronic graft-versus host
ATLANTA - Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host ...
Landmark CAR-T cancer study published in the New England Journal of Medicine
Credit: Loyola Medicine MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal ...
Rapid responses, few adverse effects in targeted agent in Phase1 trial in rare blood disorder
ATLANTA - In a Phase 1 trial, patients with an advanced or aggressive form of systemic mastocytosis (AdvSM), a rare ...
Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
Credit: Seattle Children's SEATTLE - Dec. 9, 2017 - Results from a phase 2 clinical trial, presented by Seattle Children's ...
ECOG-ACRIN discovers a simple blood test may predict recurrence of breast cancer
A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict ...
Researchers make important bacterial discovery in oral pre-cancer condition
Scientists at the School of Dental Science in Trinity have made an important discovery involving bacteria and a pre-cancerous growth ...
Is laughter the greatest medicine for cancer patients?
Credit: Lancaster University Analysis led by Lancaster University researchers suggests that spontaneous humour is used and appreciated by people with ...
UH cancer researcher focused on tumor development
Credit: University of Houston A cancer researcher at the University of Houston is set to deliver an unprecedented look at ...
Breakthroughs in understanding the genetic basis of aggressive prostate cancer
Credit: Christopher McNair, Thomas Jefferson University (PHILADELPHIA) - The retinoblastoma (RB) susceptibility gene was the first gatekeeper gene discovered for ...
